Literature DB >> 1545020

Renal vein and inferior vena cava tumor thrombus in renal cell carcinoma: CT, US, MRI and venacavography.

D A Kallman1, B F King, R R Hattery, J W Charboneau, R L Ehman, D A Guthman, M L Blute.   

Abstract

Renal cell carcinoma has a propensity to extend as tumor thrombus into the renal vein and inferior vena cava (IVC). The preoperative assessment for the presence and extent of renal vein and IVC tumor thrombus is important for planning appropriate surgical resection. Imaging procedures [CT, ultrasound (US), MR, venacavography] were correlated with surgical findings and pathology in 431 consecutive patients who had a radical nephrectomy for renal cell carcinoma. Ninety-nine (23%) patients had tumor thrombus extending at least into the main renal vein. Of these, 29 had tumor thrombus extending within the IVC. Patients were classified into two groups based on the surgical extent of tumor thrombus. Group A patients had no tumor thrombus or had tumor thrombus only in the renal vein proximal to the site of surgical ligation. Group B patients had tumor thrombus that extended to or beyond the distal renal vein at the site of surgical ligation. Forty-one patients had Group B tumor thrombus. Group B tumor thrombus was not seen in a renal cell carcinoma that was smaller than 4.5 cm. The sensitivity of CT for detecting Group B tumor thrombus was 79% and that of US was 68%. However, a much higher percentage of US examinations were technically indeterminate. In the patients who had either MR or venacavography, both imaging procedures were 100% sensitive for detecting group B tumor thrombus. Magnetic resonance imaging and venacavography appear to be the most sensitive means of identifying tumor thrombus.

Entities:  

Mesh:

Year:  1992        PMID: 1545020     DOI: 10.1097/00004728-199203000-00012

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  17 in total

1.  Locally advanced renal cell carcinoma.

Authors:  Mohammed Al Otaibi; Simon Tanguay
Journal:  Can Urol Assoc J       Date:  2007-06       Impact factor: 1.862

Review 2.  Imaging renal cell carcinoma with ultrasonography, CT and MRI.

Authors:  Michael J Leveridge; Peter J Bostrom; George Koulouris; Antonio Finelli; Nathan Lawrentschuk
Journal:  Nat Rev Urol       Date:  2010-05-18       Impact factor: 14.432

3.  Surgical resection of recurrent inferior vena cava tumor following radical nephrectomy for renal cell carcinoma: A case report.

Authors:  Guangyuan Li; Zhiqiang Zhang; Dongdong Xie; Nan Ye; Dexin Yu
Journal:  Oncol Lett       Date:  2015-05-06       Impact factor: 2.967

Review 4.  Magnetic Resonance Imaging and the Use in Small Renal Masses.

Authors:  M Vedanayagam; B Bhattacharya; S Sriprasad
Journal:  Indian J Surg Oncol       Date:  2016-12-05

5.  Transthoracic echo: A sensitive tool for detecting cardiac extension of renal cell carcinoma?

Authors:  Michelle Bejarano; Yara L Cameron; Theodore C Koutlas; Assad Movahed
Journal:  World J Clin Cases       Date:  2014-08-16       Impact factor: 1.337

6.  [Level IV inferior vena cava tumor thrombus : A rare diagnosis in patients with renal cell carcinoma].

Authors:  L Hofer; C Gasch; G Hatiboglu; J Motsch; C Grüllich; S Duensing; M Hohenfellner
Journal:  Urologe A       Date:  2017-07       Impact factor: 0.639

Review 7.  Advanced renal mass imaging: diffusion and perfusion MRI.

Authors:  Anthony G Gilet; Stella K Kang; Danny Kim; Hersh Chandarana
Journal:  Curr Urol Rep       Date:  2012-02       Impact factor: 3.092

Review 8.  Contemporary imaging of the renal mass.

Authors:  Stella K Kang; Danny Kim; Hersh Chandarana
Journal:  Curr Urol Rep       Date:  2011-02       Impact factor: 3.092

Review 9.  Long-term outcomes of the surgical management of renal cell carcinoma.

Authors:  John S Lam; Arie S Belldegrun; Allan J Pantuck
Journal:  World J Urol       Date:  2006-02-15       Impact factor: 4.226

Review 10.  Imaging in the staging of renal cell carcinoma.

Authors:  R H Reznek
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.